Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PECS Blocks for Biceps Tenodesis Analgesia
NCT02741713Phase 3Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Apr 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Post-operative Axillary Pain at 6 hours. Started Apr 2016; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02741713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02741713.